RecruitingNot ApplicableNCT06844006

Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure Patients

Assessment of Digital Care on Clinical Impact and Efficiency Using a Stepped Wedge Cluster RCT in Heart Failure Patients: the ADMINISTER II Trial


Sponsor

Medisch Spectrum Twente

Enrollment

1,320 participants

Start Date

Jun 13, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates the impact of a nudge-based intervention on improving guideline directed medical therapy (GDMT) prescription among cardiologists. Using a stepped wedge randomized controlled trial design, we assess whether digital decision support-leveraging home monitoring and clinical data-enhances adherence to guideline-recommended medication titration. The primary outcomes include HF related hospitalization rates and all cause mortality.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • All heart failure diagnoses
  • \>18 years

Exclusion Criteria4

  • Not understanding the Dutch Language.
  • Allergies that make uptitration impossible.
  • Admission to hospice or palliative care.
  • Severe psychological disorders.

Interventions

COMBINATION_PRODUCTNudging

Clinicians will be nudged with a prompt, based on remote monitoring data, current medication data, contraindications, in the electronic patient dossier whether further optimization to guideline directed medical therapy (GDMT) is possible.


Locations(1)

Medisch Spectrum Twente

Enschede, Overijssel, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06844006


Related Trials